Astrocytic ceruloplasmin expression, which is induced by IL-1β and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor

GLIA

Volumn 44, Issue 1, 2003, Pages 76-84

  Kuhlow, Christopher J ^a   Krady, J Kyle ^a   Basu, Anirban ^a   Levison, Steven W ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Ceruloplasmin; Gliosis; Interleukin 1; Metals; Oxidative stress; Traumatic brain injury

Indexed keywords

ANTIOXIDANT; CERULOPLASMIN; COPPER; FERROUS ION; FREE RADICAL; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; GENE EXPRESSION; MACROGLIA; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN INJURIES; CELLS, CULTURED; CERULOPLASMIN; GENE EXPRESSION REGULATION; GLIOSIS; INTERLEUKIN-1; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; RNA, MESSENGER;

EID: 0141504951     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10273     Document Type: Article

References (59)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
2. Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW. 2002. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of FGF-2, to increase motor neuron survival. Exp Neurol 173:46-62.
3. Allan SM, Rothwell NJ. 2001. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734-744.
4. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C. 1992. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 149:2358-2366.
5. Araujo DM, Cotman CW. 1992. Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 12:1668-1678.
6. Bandtlow CE, Meyer M, Lindholm D, Spranger M, Heumann R, Thoenen H. 1990. Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol 111:1701-1711.
7. Bartlett PF, Noble MD, Pruss RM, Raff MC, Rattray S, Williams CA. 1980. Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells, Muller cells and lepto-meninges defined by a monoclonal antibody. Brain Res 204:339-351.
8. Basu A, Krady JK, O'Malley M, Styren SD, DeKosky ST, Levison SW. 2002. The type 1 interleukin 1 receptor is essential for the efficient activation of microglia and the induction of multiple pro-inflammatory mediators in response to brain injury. J Neurosci 22:6071-6082.
9. Bauer J, Berkenbosch F, van Dam AM, Dijkstra CD. 1993. Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol 48:13-21.
10. Benveniste EN, Sparacio SM, Norris JG, Grenett HE, Fuller GM. 1990. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J Neuroimmunol 30:201-212.
11. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. 2001. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 21:5528-5534.
12. Chang JW, Young DA, Coleman PD, O'Banion MK. 2001. Two-dimensional gel analysis of secreted proteins induced by interleukin-1 beta in rat astrocytes. Neurochem Int 39:349-359.
13. Chung IY, Benveniste EN. 1990. Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144:2999-3007.
14. Connor JR, Tucker P, Johnson M, Snyder B. 1993. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett 159:88-90.
15. da Cunha A, Vitkovic L. 1992. Transforming growth factor-beta 1 (TGF-beta 1) expression and regulation in rat cortical astrocytes. J Neuroimmunol 36:157-169.
16. Deckert-Schluter M, Schluter D, Schwendemann G. 1992. Evaluation of IL-2, sIL2R, IL-6, TNF-alpha, and IL-1 beta levels in serum and CSF of patients with optic neuritis. J Neurol Sci 113:50-54.
17. DeKosky ST, Goss JR, Miller PD, Styren SD, Kochanek PM, Marion D. 1994. Upregulation of nerve growth factor following cortical trauma. Exp Neurol 130:173-177.
18. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, Yuan J. 1997. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185:933-940.
19. Friedman WJ, Thakur S, Seidman L, Rabson AB. 1996. Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. J Biol Chem 271:31115-31120.
20. Gadient RA, Cron KC, Otten U. 1990. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 117:335-340.
21. Gelman BB. 1995. Iron in CNS disease. J Neuropathol Exp Neurol 54:477-486.
22. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. 1994. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63:793-807.
23. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. 1988. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8:2485-2490.
24. Goldstein E, Chang DY, Lippert W, Tarkington B. 1979. Effect of near ambient exposures to sulfur dioxide and ferrous sulfate particles on murine pulmonary defense mechanisms. Arch Environ Health 34:424-431.
25. Gotz ME, Kung G, Riederer P, et al. 1994. Oxidative stress; free radical production in neural degeneration. Pharmacol Ther 63:37-122.
26. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, Araoz C. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
27. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA. 1997. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94:2007-2012.
28. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. 1995. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539-2543.
29. Hartung HP, Schaefer B, Heininger K, Toyka KV. 1989. Recombinant interleukin-1beta stimulates eicosanoid production in rat primary culture astrocytes. Brain Res 489:113-119.
30. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. 2002. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 22:5910-5919.
31. Herx LM, Rivest S, Yong VW. 2000. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol 165:2232-2239.
32. Herx LM, Yong VW. 2001. Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol 60:961-971.
33. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merrill JE. 1986. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol 136:3239-3245.
34. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK. 1991. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J Immunol 146:2983-2989.
35. Jenner P. 1994. Oxidative damage in neurodegenerative disease. Lancet 344:796-798.
36. Klomp LW, Farhangrazi ZS, Dugan LL, Gitlin JD. 1996. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 98:207-215.
37. Lee SC, Liu W, Dickson DW, Brosnan CF. 1995. In human fetal astrocytes exposure to interleukin-1b stimulates acquisition of the GD3+ phenotype and inhibits cell division. J Neurochem 64:1800-1807.
38. Legos JJ, Whitmore RG, Erhardt JA, Parsons AA, Tuma RF, Barone FC. 2000. Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci Lett 282:189-192.
39. Levison SW, McCarthy KD. 1991. Astroglia in culture. In: Banker G, Goslin K, editors. Culturing nerve cells. Cambridge, MA: MIT Press. p 309-336.
40. Liu XH, Kwon D, Schielke GP, Yang GY, Silverstein FS, Barks JD. 1999. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 19:1099-1108.
41. Loddick SA, Rothwell NJ. 1996. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16:932-940.
42. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L. 1996. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 738:265-274.
43. Martin D, Chinookoswong N, Miller G. 1994. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 130:362-367.
44. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. 2001. Interleukin-1beta promotes repair of the CNS. J Neurosci 21:7046-7052.
45. McGuinness MC, Powers JM, Bias WB, Schmeckpeper BJ, Segal AH, Gowda VC, Wesselingh SL, Berger J, Griffin DE, Smith KD. 1997. Human Leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol 75:174-182.
46. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M. 1992. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J Neurochem 58:390-392.
47. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. 1987. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767.
48. Morell AG, Scheinberg IH. 1958. Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper. Science 127:588-590.
49. Norris JG, Tang LP, Sparacio SM, Benveniste EN. 1994. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1beta and tumor necrosis factor-alpha. J Immunol 152:841-850.
50. Patel BN, David S. 1997. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272:20185-20190.
51. Qian ZM, Wang Q. 1998. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 27:257-267.
52. Relton JK, Rothwell NJ. 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29:243-246.
53. Roeser HP, Lee GR, Nacht S, Cartwright GE. 1970. The role of ceruloplasmin in iron metabolism. J Clin Invest 49:2408-2417.
54. Rothwell NJ, Luheshi GN. 2000. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23:618-625.
55. Salzer JL, Lovejoy L, Linder MC, Rosen C. 1998. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J Neurosci Res 54:147-157.
56. Schielke GP, Yang GY, Shivers BD, Betz AL. 1998. Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice. J Cereb Blood Flow Metab 18:180-185.
57. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN. 1992. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappaB-like nuclear protein. J Neuroimmunol 39:231-242.
58. Takahashi N, Ortel TL, Putnam FW. 1984. Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule. Proc Natl Acad Sci USA 81:390-394.
59. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676-681.